IP Verse

Once Daily Formulation Of Lacosamide

PatentPatent Analysis

EP2645997

UCB PHARMA
Application Number
EP11791442A
Filing Date
Dec 1, 2011
Status
Revoked
Sep 6, 2024
Grant Date
Aug 10, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2301961B9
EP3145504B1
EP2869844B2

Biblio Summary

The patent EP2645997B1 was granted to UCB Pharma on Aug 10, 2022 following the initial filing on Dec 1, 2011 under the application number EP11791442A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKMay 10, 2023ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents